Shalby’s step?down subsidiary -- Shalby Global Technologies, Singapore (SGT) has received a regulatory approval to market and sell Knee Implants, Hip Systems, Knee and Hip Instruments, etc. by Ministry of Health, Indonesia. Now, SGT can import the said implants and medical devices from USA and sell in Indonesia.
This development is fully in line with company’s stated strategy to grow company’s Orthopaedic implant business and establish footprint in the Medical device market internationally. This is a big milestone achieved by the Shalby group in its journey to serve many more international patients. The synergies between the businesses are compelling and will bring in immediate benefits of sourcing US FDA approved quality implants into Indonesia through company’s distribution channels. Shalby has performed more than 1,44,000 joint replacement surgeries so far and continues to be the leader in India and globally in terms of the volume of surgeries performed annually.
Shalby is a chain of Multi-specialty tertiary care hospitals based out of Ahmedabad. It has combined bed strength of more than 700 beds with its multispecialty hospitals across Gujarat and Goa.
